Cite

    Zhang, S., Jin, S., Griffin, C., Feng, Z., Lin, J., Baratta, M., Brake, R., Venkatakrishnan, K., & Gupta, N. (2021). single‐Dose Pharmacokinetics and Tolerability of the Oral Epidermal Growth Factor Receptor Inhibitor Mobocertinib (TAK‐788) in Healthy Volunteers: Low‐Fat Meal Effect and Relative Bioavailability of 2 Capsule Products. Clinical pharmacology in drug development, 10(9), 1028–1043. http://access.bl.uk/ark:/81055/vdc_100139933198.0x00000a